<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="124316">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01824173</url>
  </required_header>
  <id_info>
    <org_study_id>12-004000</org_study_id>
    <nct_id>NCT01824173</nct_id>
  </id_info>
  <brief_title>Muscle Protein Metabolism in Obesity</brief_title>
  <official_title>Regulation of Muscle ATP Synthase Beta Subunit Metabolism in Obesity</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mayo Clinic</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Mayo Clinic</source>
  <oversight_info>
    <authority>United States: Food and Drug Administration</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Obesity is associated with reduced adenosine triphosphate (ATP) turnover in skeletal muscle,
      a condition that can impair muscle metabolism. The proposed research will discover
      mechanisms responsible for decreased content in mitochondrial proteins as well as in protein
      β-F1-ATPase, which is directly responsible for ATP assembly, in the muscle of obese
      individuals. This research will further examine the effectiveness of interventions, such as
      increased plasma amino acid availability and exercise, to increase the rate of production of
      mitochondrial proteins as well as that of β-F1-ATPase in the muscle of obese individuals.
      The findings will help to develop appropriate interventions to improve muscle ATP turnover
      and metabolism in obese people.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>October 2012</start_date>
  <completion_date type="Anticipated">June 2016</completion_date>
  <primary_completion_date type="Anticipated">June 2016</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Basic Science</study_design>
  <primary_outcome>
    <measure>Rate of synthesis of muscle proteins (mixed muscle proteins, mitochondrial proteins, β-F1-ATPase)</measure>
    <time_frame>Measured during a 9-hour infusion study</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>β-F1-ATPase mRNA expression; PGC-1 expression</measure>
    <time_frame>Measured during a 9-hour infusion study</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">84</enrollment>
  <condition>Obesity</condition>
  <arm_group>
    <arm_group_label>Amino Acid Infusion in Lean</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Amino Acid Infusion in Lean</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Amino acid Infusion in Obese</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Amino acid Infusion in Obese</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Exercise in lean</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Exercise in lean</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Exercise in Obese</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Exercise in Obese</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Increase in the levels of plasma amino acids</intervention_name>
    <description>Aminosyn 15%; 160 mg/kg FFM/h for 4 hours</description>
    <arm_group_label>Amino Acid Infusion in Lean</arm_group_label>
    <arm_group_label>Amino acid Infusion in Obese</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Aerobic exercise</intervention_name>
    <description>Moderate intensity for 45 minutes</description>
    <arm_group_label>Exercise in lean</arm_group_label>
    <arm_group_label>Exercise in Obese</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion criteria:

          1. Body mass index (BMI): lean, 19-25 kg/m2; obese, 30-40 kg/m2

          2. Availability of transportation

          3. Ability to sign informed consent form

        Exclusion criteria:

          1. Medication or supplements (i.e. amino acids, protein) known to affect protein
             metabolism

          2. Presence of acute illness

          3. History of liver disease

          4. Uncontrolled metabolic disease

          5. ECG documented abnormalities, atrial fibrillation, history of syncope, limiting or
             unstable angina, or congestive heart failure

          6. Chronically elevated blood pressure (systolic, &gt;140 mmHg; diastolic, &gt;100 mmHg)

          7. Cardiac pacemaker or other medical device implanted in the body

          8. Low hemoglobin or hematocrit

          9. Current participation in a weight-loss regimen, including extreme dietary practices

         10. Smoking

         11. Use of anabolic steroids or corticosteroids (within 3 months)
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Lori Roust, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mayo Clinic</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Christos S Katsanos, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Arizona State University/Mayo Clinic Arizona</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Mayo Clinic in Arizona</name>
      <address>
        <city>Scottsdale</city>
        <state>Arizona</state>
        <zip>85259</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Early Jennifer, RN</last_name>
      <phone>480-301-4142</phone>
      <email>early.jennifer@mayo.edu</email>
    </contact>
    <contact_backup>
      <last_name>Christos Katsanos, PhD</last_name>
      <phone>480-301-6015</phone>
      <email>katsanos.christos@mayo.edu</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2014</verification_date>
  <lastchanged_date>April 24, 2014</lastchanged_date>
  <firstreceived_date>April 1, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Mayo Clinic</investigator_affiliation>
    <investigator_full_name>Lori R. Roust</investigator_full_name>
    <investigator_title>PI</investigator_title>
  </responsible_party>
  <keyword>muscle</keyword>
  <keyword>mitochondria</keyword>
  <keyword>amino acids</keyword>
  <keyword>exercise</keyword>
  <is_fda_regulated>Yes</is_fda_regulated>
  <is_section_801>Yes</is_section_801>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Obesity</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
